[Thymalin as a modulator of immunogenesis and hemostasis].
Studies made in 30 patients with periodontosis have shown that thymaline improves the general health status of patients, thereby promoting the normalization of cellular and, to a lesser degree, humoral immunity. At the same time the drug normalizes blood coagulation, the total and Hageman factor-dependent fibrinolysis. It is concluded that thymaline is a modulator of the immunogenesis and hemostasis.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D010520:Aggressive Periodontitis / Q000188:drug therapy / Q000503:physiopathology; D000917:Antibody Formation / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects; D003165:Complement System Proteins / Q000032:analysis; D004341:Drug Evaluation; D005342:Fibrinolysis / Q000187:drug effects; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D006490:Hemostatics; D007136:Immunoglobulins; D013951:Thymus Hormones; C032805:thymalin; D003165:Complement System Proteins
Timalik kak moduliator immunogeneza i gemostaza.